Xofigo® (radium Ra 223 dichloride)
Battle in the Bone

Credits
Agency Network | FCB Health Network |
Advertiser Brand | Bayer Pharmaceuticals, Inc./Xofigo® (radium Ra 223 dichloride), Whippany, NJ |
Entrant Company | Area 23, An FCB Health Network Company, New York |
Design Company | Lightfarm, Rio de Janeiro |
EVP, Managing Director | Tim Hawkey / Area 23, An FCB Health Network Company |
SVP, Group Creative Director | Bernardo Romero / Area 23, An FCB Health Network Company |
SVP, Creative Director | Jesse Kates / Area 23, An FCB Health Network Company |
VP, Associate Creative Director | Daniel Plansky / Area 23, An FCB Health Network Company |
VP, Associate Creative Director | Nathaniel Kuritz / Area 23, An FCB Health Network Company |
Group Art Supervisor | Sandee Shin / Area 23, An FCB Health Network Company |
Group Copy Supervisor | Katie DeMarco / Area 23, An FCB Health Network Company |
Associate Director, Print Production | Frank Laport / Area 23, An FCB Health Network Company |
Senior Production Manager | Laurette Mercer / Area 23, An FCB Health Network Company |
SVP, Management Director | Lea Argenti / Area 23, An FCB Health Network Company |
Account Supervisor | Morgan Carey / Area 23, An FCB Health Network Company |
Director | Milton Menezes / Lightfarm |
Creative Director | Rafael Vallaperde / Lightfarm |
Production Manager | Thadeu Felix / Lightfarm |
VP, Account Director | Despina Mahles |
This 2018 Clio Health Silver winning entry titled 'Battle in the Bone' was entered for Xofigo® (radium Ra 223 dichloride) by Area 23, An FCB Health Network Company, New York. The advertising agency is part of the agency network: FCB Health Network. The piece was submitted to the medium: Print (Pharmaceutical) within the entry type: Disease Awareness. It consists of 1 image.
Follow Us